D.A. Davidson & Co’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,450
Closed -$131K 1739
2017
Q2
$131K Sell
5,450
-1,140
-17% -$25K ﹤0.01% 1152
2017
Q1
$130K Sell
6,590
-564
-8% -$12.6K ﹤0.01% 1129
2016
Q4
$172K Buy
7,154
+505
+8% +$14.1K ﹤0.01% 1069
2016
Q3
$184K Buy
6,649
+5,499
+478% +$145K ﹤0.01% 980
2016
Q2
$28K Buy
1,150
+1,009
+716% +$28.6K ﹤0.01% 1642
2016
Q1
$4K Hold
141
﹤0.01% 2085
2015
Q4
$4K Buy
+141
New +$4.75K ﹤0.01% 2056

Other funds holding PGEN

D.A. Davidson & Co's PGEN Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Precigen (PGEN) in Q3 2017, closing a stake of 5,450 shares — an estimated $131K sold.

D.A. Davidson & Co first reported a position in PGEN in Q4 2015 and held it in 7 quarters. The position peaked at $184K in Q3 2016. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 5,450 Precigen shares in Q3 2017, an estimated $131K.
  • D.A. Davidson & Co first reported a position in Precigen in Q4 2015 and held it in 7 quarters.
  • D.A. Davidson & Co's Precigen position peaked at $184K in Q3 2016.
  • 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.